Dienogest and the breast
Schindler AE et al. - In a clinical pilot study, 21 women with endometriosis have been primarely treated with dienogest for 24 weeks. Besides the effect on endometriosis the action of such high-dose progestogen treatment on the breast was evaluated by breast ultrasound prior to medication and at 24 weeks of medical treatment. In all women, a significant size reduction of the mammary gland (p < 0.023) and regression of mastopathic changes were observed. [more...]
|
|
|
